Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nudix hydrolase 16 (NUDT16) is a member of the Nudix hydrolase superfamily, functioning as a dimeric metalloenzyme that catalyzes the hydrolysis of nucleoside diphosphate bonds in diverse substrates. It acts as a decapping enzyme for small nucleolar RNA (snoRNA), particularly U8 snoRNA, as well as capped mRNA, removing methylated guanosine caps in the presence of divalent cations such as Mg²⁺ or Mn²⁺[2][4][6]. Beyond its canonical RNA decapping activity, NUDT16 plays "housecleaning" roles: it eliminates hazardous (deoxy)inosine diphosphate and ADP-ribosylated nucleotide derivatives from the nuclear and cytoplasmic pools, thereby protecting genomic integrity and regulating cell proliferation[1][3][5]. Structurally, NUDT16 consists of a Nudix motif that coordinates substrate and metal ion binding and regulates substrate specificity[1][5]. Loss of NUDT16 function leads to DNA single-strand breaks, increased cell arrest, and impaired cell growth, highlighting its critical cellular role[1][3][5]. Its activity and specificity are tightly regulated by substrate and product binding, with IMP (inosine monophosphate) acting as a feedback inhibitor[3]. Currently, no drugs are clinically known to target NUDT16 directly.
Hydrolysis of nucleoside diphosphates (e.g., inosine diphosphate, ADP-ribose). Decapping of mRNA and snoRNA by removal of methylated guanosine cap structures[2][4][6]. Degradation of hazardous nucleotide analogs, prevention of accumulation in cells[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nudix hydrolase 16 (NUDT16).